Literature DB >> 18379735

Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease.

Giulio Scigliano1, Gabriele Ronchetti, Floriano Girotti.   

Abstract

Alterations of the cardiovascular system and of the glucose and lipid metabolism can represent important factors of vascular risk. The autonomic nervous system, through its two efferent branches, the parasympatheticcholinergic and the sympathetic-adrenergic, plays an important role in the control of the cardiovascular activity and of the glucose and lipid metabolism, and its impaired working can interfere with these functions. An increased sympathetic activity and an increased frequency of diabetes, dyslipidemia, hypertension and obesity have been reported in untreated schizophrenic patients, and a further worsening of these vascular risk factors has been signalled as a side effect of treatment with neuroleptic drugs. The opposite is observed in Parkinson's disease, where the reduced autonomic activity induced by the illness is associated with a decreased frequency of vascular risk factors, and their occurrence is further reduced by the treatment with dopaminergic drugs.

Entities:  

Mesh:

Year:  2008        PMID: 18379735     DOI: 10.1007/s10072-008-0853-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  73 in total

Review 1.  Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function.

Authors:  Bernard Bruguerolle; Nicolas Simon
Journal:  Clin Neuropharmacol       Date:  2002 Jul-Aug       Impact factor: 1.592

2.  Atypical antipsychotics related metabolic syndrome in bipolar patients.

Authors:  Mehmet Yumru; Haluk A Savas; Erhan Kurt; M Cemal Kaya; Salih Selek; Esen Savas; E Timucin Oral; Ilhan Atagun
Journal:  J Affect Disord       Date:  2006-09-12       Impact factor: 4.839

3.  Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity.

Authors:  Paolo Palatini; Daniele Longo; Vania Zaetta; Davor Perkovic; Raffaella Garbelotto; Achille C Pessina
Journal:  J Hypertens       Date:  2006-07       Impact factor: 4.844

4.  Levodopa reduces risk factors for vascular disease in parkinsonian patients.

Authors:  Giulio Scigliano; Gabriele Ronchetti; Floriano Girotti; Massimo Musicco
Journal:  J Neurol       Date:  2008-05-30       Impact factor: 4.849

5.  Differential responses of plasma aldosterone, cortisol and adrenocorticotropin to two dopamine receptor antagonists.

Authors:  J Staessen; R Fiocchi; R Bouillon; R Fagard; P Lijnen; W Lissens; A Amery
Journal:  Methods Find Exp Clin Pharmacol       Date:  1985-10

6.  Autonomic activity in relation to symptom ratings and reaction time in unmedicated patients with schizophrenia.

Authors:  Theodore P Zahn; David Pickar
Journal:  Schizophr Res       Date:  2005-07-11       Impact factor: 4.939

7.  Dopamine and the kidney: ten years on.

Authors:  M R Lee
Journal:  Clin Sci (Lond)       Date:  1993-04       Impact factor: 6.124

8.  Effect of parasympathetic denervation of liver and pancreas on glucose kinetics in man.

Authors:  S E Fabris; A Thorburn; A Litchfield; J Proietto
Journal:  Metabolism       Date:  1996-08       Impact factor: 8.694

Review 9.  Neuropathology of autonomic nervous system in Parkinson's disease.

Authors:  K Wakabayashi; H Takahashi
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

Review 10.  Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports.

Authors:  Elizabeth A Koller; James T Cross; P Murali Doraiswamy; Saul N Malozowski
Journal:  Pharmacotherapy       Date:  2003-09       Impact factor: 4.705

View more
  3 in total

1.  Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge.

Authors:  José Ángel García-Pedraza; Asunción Morán; María Luisa Martín; Claudia Ollauri-Ibáñez; Alicia Rodríguez-Barbero; Carlos M Villalón; Mónica García-Domingo
Journal:  Pflugers Arch       Date:  2020-08-21       Impact factor: 3.657

2.  Serum adiponectin levels in advanced-stage Parkinson's disease patients.

Authors:  Erica Cassani; Raffaella Cancello; Ferruccio Cavanna; Sabrina Maestrini; Anna Maria Di Blasio; Antonio Liuzzi; Gianni Pezzoli; Michela Barichella
Journal:  Parkinsons Dis       Date:  2011-06-16

3.  Influence of Acute Antipsychotic Treatment on Cardiorespiratory Coupling and Heart Rate Variability.

Authors:  Roboam R Aguirre; Mixel Z Mustafa; Alessandra Dumenigo; Steffen Schulz; Andreas Voss; Bishoy Goubran; Rhaisa Dumenigo; Marcos A Sanchez-Gonzalez
Journal:  Cureus       Date:  2018-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.